Wannian M. Zhang

325 Guohe Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications

Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review

Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026

Recent developments in matrine as a versatile molecular scaffold in small molecule drug discovery.

Recent developments in matrine as a versatile molecular scaffold in small molecule drug discovery.

Journal: Future medicinal chemistry
Published: June 11, 2025

Design of anti-depressant phosphodiester amino acidic Keap1-Nrf2 protein-protein interaction inhibitors.

Design of anti-depressant phosphodiester amino acidic Keap1-Nrf2 protein-protein interaction inhibitors.

Journal: Redox biology
Published: February 02, 2025

Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatment.

Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatment.

Journal: Bioorganic chemistry
Published: January 07, 2025

Labeled and Label-Free Target Identifications of Natural Products.

Labeled and Label-Free Target Identifications of Natural Products.

Journal: Journal of medicinal chemistry
Published: October 03, 2024

Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent.

Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent.

Journal: Journal of medicinal chemistry
Published: June 28, 2024

Structure-Activity Relationship Study of (E)-3-(6-Fluoro-1H-indol-3-Yl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (FC116) Against Metastatic Colorectal Cancers Resistant to Oxaliplatin.

Structure-Activity Relationship Study of (E)-3-(6-Fluoro-1H-indol-3-Yl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (FC116) Against Metastatic Colorectal Cancers Resistant to Oxaliplatin.

Journal: ACS pharmacology & translational science
Published: January 19, 2024

Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway.

Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway.

Journal: Food & function
Published: December 12, 2023

Diallyl Disulfide Blocks Cigarette Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Lung Tumorigenesis via Activation of the Nrf2 Antioxidant System and Suppression of NF-κB Inflammatory Response.

Diallyl Disulfide Blocks Cigarette Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Lung Tumorigenesis via Activation of the Nrf2 Antioxidant System and Suppression of NF-κB Inflammatory Response.

Journal: Journal of agricultural and food chemistry
Published: November 13, 2023

Pharmacokinetic, Tissue Distribution, Metabolite, and Toxicity Evaluation of the Matrine Derivative, (6aS, 10S, 11aR, 11bR, 11cS)-10-Methylaminododecahydro-3a, 7a-Diaza-benzo (de) Anthracene-8-thione.

Pharmacokinetic, Tissue Distribution, Metabolite, and Toxicity Evaluation of the Matrine Derivative, (6aS, 10S, 11aR, 11bR, 11cS)-10-Methylaminododecahydro-3a, 7a-Diaza-benzo (de) Anthracene-8-thione.

Journal: Molecules (Basel, Switzerland)
Published: October 18, 2023

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease.

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease.

Journal: Redox biology
Published: May 04, 2023

Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present).

Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present).

Journal: Expert opinion on therapeutic patents
Published: March 24, 2023
Showing 1-12 of 91

Last Updated: 09/26/2026